Marc Duey's most recent trade in Aprea Therapeutics Inc was a trade of 21,459 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on Dec. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aprea Therapeutics Inc | Marc Duey | Director | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 10 Dec 2025 | 21,459 | 256,155 (1%) | 0% | 1.2 | 25,000 | Common Stock |
| Aprea Therapeutics Inc | Marc Duey | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Dec 2025 | 21,459 | 21,459 | - | - | Common Warrant | |
| Aprea Therapeutics Inc | Marc Duey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Marc Duey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 1,045 | 234,696 (1%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Marc Duey | Director | Sale of securities on an exchange or to another person at price $ 4.58 per share. | 18 Oct 2024 | 6,462 | 233,651 (1%) | 0% | 4.6 | 29,583 | Common Stock |
| Aprea Therapeutics Inc | Marc Duey | Director | Purchase of securities on an exchange or from another person at price $ 4.39 per share. | 16 Oct 2024 | 30,000 | 240,113 (1%) | 0% | 4.4 | 131,700 | Common Stock |
| Aprea Therapeutics Inc | Marc Duey | Director | Purchase of securities on an exchange or from another person at price $ 2.58 per share. | 14 Oct 2024 | 190 | 210,113 (1%) | 0% | 2.6 | 490 | Common Stock |
| Aprea Therapeutics Inc | Marc Duey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Marc Duey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 1,045 | 209,923 (1%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Marc Duey | Director | 23 Aug 2023 | 4,009,690 | 4,167,589 (19%) | 19% | 0 | Common Stock | ||
| Aprea Therapeutics Inc | Marc Duey | Director | 23 Aug 2023 | 400,969 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | ||
| Aprea Therapeutics Inc | Marc Duey | Director | 23 Aug 2023 | 11,610 | 602 (0%) | 0% | 0 | Common Stock | ||
| Aprea Therapeutics Inc | Marc Duey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 2,000 | 2,000 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Marc Duey | Director | 23 Aug 2023 | 1,161 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | ||
| Aprea Therapeutics Inc | Marc Duey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 500 | 208,878 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Marc Duey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 29,575 | 29,575 | - | - | Stock Option (right to Buy) | |
| Aprea Therapeutics Inc | Marc Duey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 5,995 | 157,899 (0%) | 0% | 0 | Common Stock |